Millipore’s Acquisition by Merck KGaA

On February 28, 2010, Merck KGaA and Millipore Corporation announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore for a total transaction value, including net debt, of approximately $7.2 billion. Pursuant to the Plan of Share Exchange, each share of Millipore common stock will be acquired by Merck in exchange for the right to receive $107 in cash according to a statutory share exchange under the laws of Massachusetts. The transaction was approved by the boards of directors of both companies.

The Cravath team includes partners Robert I. Townsend and George E. Zobitz and associates Joseph D. Zavaglia and Brian M. Malbacho on corporate matters; associates Lori Diamond Goodman and Kevin E. Manz on executive compensation and benefits matters; partner Michael L. Schler and associate Mark E. Dundon on tax matters; and associate Annmarie M. Terraciano on environmental matters.